The Florida Department of Health (DOH) Guidance
The Florida Department of Health (DOH) Guidance stated: “Based on the currently available evidence, encouraging mastectomy, ovariectomy, uterine extirpation, penile disablement, tracheal shave, the prescription of hormones which are out of line with the genetic make-up of the child, or puberty blockers, are all clinical practices which run an unacceptably high risk of doing harm.
The guidance document also noted “a lack of conclusive evidence” for “gender transitioning” and “the potential for long-term, irreversible effects,” as well as analysis of the benefits of hormonal interventions “show a trend of low-quality evidence, small sample sizes, and medium to high risk of bias.” In addition, “80 percent of minors of those seeking clinical care will lose their desire to identify with the nonbirth sex.”
The Florida DOH Guidance also includes:
- “Social gender transition should not be a treatment option for children or adolescents.
- Anyone under 18 should not be prescribed puberty blockers or hormone therapy.
- Gender reassignment surgery should not be a treatment option for children or adolescents.
- Children and adolescents should be provided social support by peers and family and seek counseling from a licensed provider.”
The guidance refers to a study, “Clinical and Ethical Considerations in the Treatment of Gender Dysphoric Children and Adolescents: When Doing Less Is Helping More,” which determines that “through an analysis of recently published treatment protocols, research findings and clinical experience, and guided by the principle of ‘first, do no harm,’ the author argues that the use of pharmacological and surgical interventions in the treatment of gender dysphoric youth, especially in light of what is known about the transience of cross-gender identification in children, is mistaken both clinically and ethically.”